Work

The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen

Year: 2009

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2009.03.069

Authors: Afton L. McGowen, Laura P. Hale, Christopher P. Shelburne, Soman N. Abraham, Herman F. Staats

Institution: Duke Medical Center

Language: English

Topic: Bacillus and Francisella bacterial research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of Allergy and Infectious Diseases

Award: Mast Cell Activator as Adjuvant for Biodefense Vaccines

OpenAlex ID: W2088919776

FWCI: 3.5

Cites: 73

Cited by: 79

Related to: 10